Stocktoria
Imunon, Inc. IMNN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1993-10-27
Imunon, Inc. statistics & valuation
Market cap$7.5M
P / B1.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | -4984.3% | -4201.4% |
| Net margin | — | — | — | -7179.6% | -4153.9% |
| FCF margin | — | — | — | -4672.9% | -3307.0% |
| Return on assets | -118.0% | -191.6% | -89.0% | -81.6% | -28.0% |
| Return on equity | -205.3% | -438.7% | -145.8% | -122.4% | -37.2% |
| Debt / equity | — | — | — | 0.20× | — |
| Current ratio | 2.32 | 1.67 | 2.47 | 3.66 | 7.67 |
| Revenue growth | — | — | — | 0.0% | 0.0% |
Source: SEC EDGAR filings · CIK 0000749647 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.